Amophar OTC
0795.483.142 · rovalta.com · 25/09/2026
Amophar OTC
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOAmophar OTC is a Private limited company incorporated in 2022. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Schelle.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0795.483.142
- Incorporation
- 28/12/2022
- Legal form
- Private limited company
- Registered office
- Molenberglei 36
2627 Schelle · FlandreSee on map - Contributed capital
- 10 000,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 0,0 ETP
Financials
Source · NBB, 3 filingsTrend over 3 financial years
| 2025 | 2024 | 2023 | |||
|---|---|---|---|---|---|
| Income statement | |||||
| Gross margin | 4,3 k € | +350% | -1,7 k € | -139% | 4,4 k € |
| EBITDA | 3,6 k € | +308% | -1,7 k € | -163% | 2,7 k € |
| Operating result | 3,6 k € | +308% | -1,7 k € | -163% | 2,7 k € |
| Net result | 3,7 k € | +2091% | 170 € | -84.9% | 1,1 k € |
| Balance sheet | |||||
| Equity | 15 k € | +33.0% | 11,3 k € | +1.5% | 11,1 k € |
| Total assets | 272,8 k € | +72.0% | 158,6 k € | -67.1% | 482,8 k € |
| Cash | 344,7 € | -98.8% | 29,4 k € | +2460% | 1,1 k € |
| Debts | 257,8 k € | +1079% | 21,9 k € | -95.4% | 471,7 k € |
| Other | |||||
| Workforce | 0,0 ETP | – | – | ||
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/2025Other companies at this address
Molenberglei 36 2627 Schelle| Company | CBE no. |
|---|---|
ALL-in-1● Active | 0864.603.461 |
AMOPHAR● Active | 0839.385.540 |
INPHAGRO● Active | 0664.787.322 |
KDT Consulting● Active | 0877.577.806 |
LIFE MEDICAL● Active | 0561.721.456 |
WOLFMAN● Active | 0750.605.497 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 28/12/2022 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 |
| Length of the financial year | 12 months | 12 months | 13 months |
| Filing date | 09/07/2026 | 26/06/2025 | 08/10/2024 |
| General meeting | 30/06/2026 | 10/06/2025 | 02/10/2024 |
| Currency of the financial year | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 3 filingsValuation
Indicative valuation
As an indication, this company is worth
between 0 € and 100 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/2025Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Other30/12/2022RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 20253,7 k €↑
- 2024Annual accounts 2024170 €↓
- 2023Annual accounts 20231,1 k €
- 28/12/2022IncorporationPrivate limited company